Kopp Family Office, LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed December 31, 2024), Kopp Family Office, LLC reported 22 stock positions worth $157.0 million. Its top holding was Vanguard Ftse Developed ETF (VEA) at 20.6% of the portfolio, followed by Vanguard Ftse Emerging Marke (VWO, 12.1%) and Vericel (VCEL, 10.0%). Compared with Q2 2024, it opened 2 new positions, sold out of 1 and reduced 5. The biggest buy was a new position in iShares Core U.S. Aggregate (AGG) and the biggest sale iShares Russell 2000 ETF (IWM, shares −62%).
- Most Recent 13F
- Q2 2026
- Location
- MINNETONKA, MN
- CIK
- 0001683689
- Portfolio Value
- $157.0M (Q3 2024)
- SEC Filing
- 0001683689-24-000005 ↗ filed Dec 31, 2024
Holdings Value
Holdings 22 stocks · $157.0M
| VEA Vanguard Ftse Developed ETF | 20.63% | 613,515 | $32.4M | Reduce -0.1% |
| VWO Vanguard Ftse Emerging Marke | 12.12% | 397,835 | $19.0M | Reduce -0.1% |
| VCEL Vericel Corp. | 10.03% | 372,948 | $15.8M | Reduce -18.5% |
| NEO Neogenomics Inc. | 8.71% | 926,975 | $13.7M | Reduce -1.9% |
| FIVN FIVE9 Inc. | 6.44% | 352,075 | $10.1M | No change |
| AGG iShares Core U.S. Aggregate | 6.26% | 97,000 | $9.8M | New |
| IWM iShares Russell 2000 ETF | 6.14% | 33,955 | $9.6M | Reduce -61.8% |
| WK Workiva Inc. | 5.63% | 111,708 | $8.8M | No change |
| INSP Inspire Medical Systems Inc. | 5.52% | 41,065 | $8.7M | No change |
| TEAM Atlassian Corp. Ltd. Class A | 5.03% | 49,694 | $7.9M | No change |
| JAMF Jamf Holding Corp. filed as JAMF HLDG CORP | 4.45% | 402,519 | $7.0M | No change |
| NTNX Nutanix Inc. Class A | 3.69% | 97,664 | $5.8M | No change |
| VRDN Viridian Therapeutics Inc. | 2.98% | 205,737 | $4.7M | No change |
| RSP Invesco S&P 500 Equal Weight | 2.05% | 18,000 | $3.2M | New |
| IVV iShares Core S&P 500 ETF | 0.07% | 197 | $114K | No change |
| IEFA iShares Core MSCI Eafe ETF | 0.07% | 1,400 | $109K | No change |
| ISTB iShares Core 1-5 Year Usd Bo | 0.06% | 2,015 | $98K | No change |
| IEMG iShares Core MSCI Emerging | 0.04% | 1,150 | $66K | No change |
| IAGG iShares Intl Aggregate Bond | 0.03% | 806 | $42K | No change |
| IMTB iShares Core 5-10 Year Usd | 0.02% | 834 | $37K | No change |
| IJH iShares Core S&P Midcap ETF | 0.02% | 565 | $35K | No change |
| IJR iShares Core S&P Small-Cap E | 0.01% | 164 | $19K | No change |
Portfolio Sells Q2 2024 → Q3 2024
| IWM iShares Russell 2000 ETF | Reduce -61.8% | 6.14% | −8.34 |
| VCEL Vericel Corp. | Reduce -18.5% | 10.03% | −2.99 |
| MITK Mitek Systems Inc. | Sold out | 0.00% | −1.64 |
| NEO Neogenomics Inc. | Reduce -1.9% | 8.71% | +0.58 |
| VWO Vanguard Ftse Emerging Marke | Reduce -0.1% | 12.12% | +1.31 |
| VEA Vanguard Ftse Developed ETF | Reduce -0.1% | 20.63% | +1.80 |
Portfolio Buys Q2 2024 → Q3 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 29 | $163.2M | AGG, VEA, RSP, SPY, VWO |
| Q1 2026 | 21 | $145.3M | VEA, AGG, RSP, SPY, VWO |
| Q4 2025 | 21 | $156.7M | VEA, RSP, IJH, VWO, AGG |
| Q3 2025 | 26 | $153.6M | VEA, VWO, RSP, IJH, AGG |
| Q2 2025 | 27 | $154.5M | VEA, VWO, RSP, AGG, IJH |
| Q1 2025 | 28 | $144.7M | VEA, VWO, AGG, FIVN, WK |
| Q4 2024 | 21 | $157.8M | VEA, VWO, VCEL, NEO, FIVN |
| Q3 2024 | 22 | $157.0M | VEA, VWO, VCEL, NEO, FIVN |
| Q2 2024 | 21 | $161.2M | VEA, IWM, VCEL, VWO, FIVN |
| Q1 2024 | 21 | $175.1M | VEA, IWM, VCEL, VWO, FIVN |